Sun Pharma |

Sun Pharma manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients.

What section would you like to update?
  • Company Logo
  • Company Name & URL
  • Company Description
  • Founded Date
  • Company Status
  • HQ Address
  • Social Links
  • CEO Name & Picture
  • Competitor Set
  • Funding Events
  • Acquisition Events

If you'd like to make any changes to this portfolio we'd be happy to help. Please send info/sources to support@owler.com.


We'll be back up as soon as possible.

Visit owler.uservoice.com for FAQs

Sun Pharma Revenue, Funding, Number of Employees, Competitors and Acquisitions

SUN PHARMA CEO

Dilip S. Shanghvi

Managing Director

Dilip S. Shanghvi

Approval Rating: 68/100

WEIGH-IN

How would you rate Dilip S. Shanghvi as a CEO?

negative
You
neutral
You
positive
You

Founded:

1983

Headquarters:

MumbaiMaharashtra

Status:

PublicNational Stock Exchange of IndiaSUNPHARMA

Industry Sector:

Pharmaceuticals

Completeness:

100%

KEY STATS

Revenue

- -

What is Sun Pharma's revenue?

<1M

Employees

- -

How many people work at Sun Pharma?

Followers on Owler

- -

FOLLOW
UNFOLLOW

TOP COMPETITORS

Add a new competitor:

Thanks for your contribution!

Recalculating The Competitive Graph now...

ADD

Sun Pharma was founded in 1983 and its headquarters is located in Mumbai, Maharashtra, IN. Sun Pharma has $4.4B in revenue and 30000 employees. Sun Pharma's top competitors are Mylan, Hospira and Wockhardt.

Sun Pharma Competitive Set

COMPANYLEADERSHIPCEO SCORE

EMPLOYEES
(ESTIMATED IF PRIVATE)

TOTAL FUNDING

REVENUE
(ESTIMATED IF PRIVATE)

LIKELY OUTCOME
Sun PharmaSun Pharma ceo

Dilip S. Shanghvi

Managing Director

68/100
1Mylan ceoMylan

Heather Bresch

CEO

42/10035,000
$11B
2Hospira ceoHospira

F. Michael Ball

CEO

50/10019,000
$4.6B
3Wockhardt ceoWockhardt

Habil Khorakiwala

Founder & CEO

74/1007,900
4Zydus ceoZydus

Pankaj R. Patel

Managing Director

77/10012,227
$54.7B
5Glenmark ceoGlenmark

Glenn Saldanha

CEO

85/1007,000
$824.9M
6Aurobindo Pharma ceoAurobindo Pharma

Govindarajan Narayanan

Managing Director

74/10013,288
$1.6B
7Cipla ceoCipla

Umang Vohra

CEO

65/10023,043
$2.3B
8Intas Pharmaceuticals ceoIntas Pharmaceuticals

Nimish Chudgar

Managing Director

58/1003,800
$604.3M

Sun Pharma Revenue History

company revenue img

Coming soon with Owler Pro!

If you'd like to learn more, please contact us at support@owler.com

$

Community Estimate

UPDATE THIS

Sun Pharma Employee History

company revenue img

Coming soon with Owler Pro!

If you'd like to learn more, please contact us at support@owler.com

Community Estimate

UPDATE THIS

Sun Pharma Leadership

NAMETITLESOCIAL MEDIA
Dilip S. Shanghvi
Dilip S. Shanghvi

Managing Director

Managing Director

Sun Pharma Acquisitions

COMPANY ACQUIRED ACQUISITION DATEAMOUNTDESCRIPTION
Zenotech Laboratories LimitedZenotech Laboratories LimitedJul 201713.2MZenotech is a pharmaceutical company that specializes in oncology, bio-technology and general injectable products.
JSC BiosintezJSC BiosintezNov 201624MBiosintez is a manufacturer of active pharmaceutical substances such as injections, tablets, ointments and infusions for the hospital industry.
InSite Vision, Inc.InSite Vision, Inc.Sep 201548MInSite Vision is engaged in developing ophthalmic pharmaceutical products to address unmet eye care needs in the United States.
Pharmalucence Inc.Pharmalucence Inc.Jul 2014undisclosedPharmalucence manufactures and markets human injectable pharmaceuticals.
DUSA Pharmaceuticals, Inc.DUSA Pharmaceuticals, Inc.Nov 2012$230MDUSA Pharmaceutical develops dermatology products for the treatment of actinic keratoses and acne.
undefinedFeb 2011undisclosed

SEE MORE

SEE LESS

Sun Pharma has acquired 6 companies.Sun Pharma's latest acquisition was Zenotech Laboratories Limited in Jul 2017. Zenotech is a pharmaceutical company that specializes in oncology, bio-technology and general injectable products.

Sun Pharma Investments

COMPANYDESCRIPTIONSTATUSINVESTMENT DATE/SOURCEROUNDEXIT DATEFOLLOW
Krystal Biotech is engaged in developing gene therapies for the treatment of rare debilitating disorders and orphan diseases.PrivateAug 07, 2017Series A
Enceladus develops liposomal formulations of corticosteroids to treat inflammatory and autoimmune diseases and cancer.PrivateOct 20, 2015Equity

Sun Pharma has acquired 6 companies.Sun Pharma's latest acquisition was Zenotech Laboratories Limited in Jul 2017. Zenotech is a pharmaceutical company that specializes in oncology, bio-technology and general injectable products.

Sun Pharma News

Sun Pharma: SC rejects Ranbaxy promoters' petition to challenge HC ruling in favour of Daiichi SankyoRanbaxy Laboratories Ltd had allegedly concealed information about proceedings against them by American food and drug department.Zee News
Sun Pharma: Industry facing pricing competition problems: Sun PharmaThe EY Entrepreneur of The Year Awards was held in Mumbai. From the sidelines, Priya Sheth caught up with Dilip Shanghvi of Sun Pharmaceutical Industries and began by asking his outlook on pharma industry amid rising pricing pressure.Moneycontrol
Sun Pharma: Sun Pharmaceutical Industries Ltd allots 13834 sharesSun Pharmaceutical Industries Ltd allots 13834 shares...Equity Bulls
Sun Pharma: US drags down Sun Pharma's overall Q3FY18 earnings; consolidated PAT declines 75% yoy The company posted consolidated profit after tax (PAT) of Rs 365.39 crore - declining by 75.17% compared to Rs 1,471.82 crore in the corresponding period of the previous year.Zee Business
Sun Pharma: Sun Pharma quarterly profit plunges on weak U.S. sales(Reuters) - India's largest drugmaker Sun Pharmaceutical Industries Ltd reported a 75 percent plunge in third-quarter net profit on Wednesday as pricing pressures in the United States, its biggest market, hit sales.Reuters
Sun Pharma: SUN PHARMACEUTICAL SCRIP DIPS 3 PERCENT AFTER Q3 RESULTSNew Delhi: Shares of drug major Sun Pharmaceutical Industries today fell nearly 3 percent after the company reported 75 percent dip in its consolidated net profit for the third quarter ended December 2017.btvi
Sun Pharma: Sun Pharma hit with another fire at an Indian plantSun Pharma says there was no direct loss of production at its Gujarat active pharmaceutical ingredient (API) facility following a fire last week.in-PharmaTechnologist
Press Release: Sun Pharma : Sun Pharma Announces Twelve Tildrakizumab Abstracts to be Presented at American Academy of Dermatology 2018 Annual MeetingSun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associate companies) today announced that 12 abstracts featuring data on the investigational, high-affinity IL-23p19 inhibitor tildrakizumab will be presented at the 76th Annual Meeting of the American Academy of Dermatology (AAD) from February 16 – 20 in San Diego, CA.StreetInsider
Sun Pharma: Sun Pharma gains as USFDA inspection starts at HalolThe positive outcome of the inspection will remove the overhang on the stock.India Infoline
Sun Pharma: Sun Pharmas subsidiary Taro reports weak earningsWhile volumes surged, an increase in competition and pricing pressure led to decline in the net sales.India Infoline

SEE MORE

SEE LESS

Sun Pharma Website History

Screengrabs of how the Sun Pharma site has evloved. (Click to expand)

Sun Pharma website history

Jan 2018

Sun Pharma website history

Jul 2017

Sun Pharma website history

Jun 2017

Sun Pharma website history

Feb 2017

Sun Pharma website history

Nov 2016

Sun Pharma website history

Aug 2016

Sun Pharma website history

May 2016

Sun Pharma website history

Feb 2016

Sun Pharma website history

Nov 2015

Sun Pharma website history

Aug 2015

Sun Pharma website history

May 2015

Sun Pharma website history

Feb 2015

Sun Pharma website history

Nov 2014

Sun Pharma website history

Aug 2014

Sun Pharma website history

May 2014

Owler has collected 15 screenshots of Sun Pharma's website since May 2014. The latest Sun Pharma website design screenshot was captured in Jan 2018.

Sun Pharma Headquarters

undefined company logo

Sun House, CTS No. 201 B/1 Western Express Highway, Goregaon East

Mumbai, Maharashtra 400063

91-22-4324-4324

Driving Directions

google map

Sun Pharma Summary Information

Sun Pharma manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients. Sun Pharma was founded in 1983. Sun Pharma's headquarters is located in Mumbai, Maharashtra, IN 400063. Sun Pharma's Managing Director, Dilip S. Shanghvi, currently has an approval rating of 68%. 65% of Owler community believes the stock will go Up. Sun Pharma has 30000 employees and reported 4.4B in revenue [trailing four quarters].

Sun Pharma's Managing Director, Dilip S. Shanghvi, currently has an approval rating of 68%. Sun Pharma's primary competitors are  Mylan Hospira Wockhardt.

Visit the Sun Pharma website to learn more.